The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease

Pelbreton C. Balfour, Carlos J. Rodriguez, Keith C. Ferdinand

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations


Race-ethnic disparities in cardiovascular disease (CVD) have persisted in the USA over the past few decades. Hypertension (HTN) is a significant contributor to CVD, including coronary heart disease, stroke, end-stage kidney disease and overall mortality and race-ethnic disparities in longevity. Additionally, both non-Hispanic blacks (NHBs) and Hispanic adults have been known to have higher prevalence of poorly controlled blood pressure compared to non-Hispanic whites (NHWs). Addressing these disparities has been a focus of programs such as the Million Hearts initiative. This review will provide an update of available data on HTN in various race-ethnic groups, including awareness, treatment, and control and note the recent progress in HTN control across all race/ethnic groups. We will also discuss the recent 2014 U.S. HTN guideline that has led to debate regarding the potential impact of BP goals in older persons on worsening CVD disparities, with disproportionate effects on women and NHBs.

Original languageEnglish (US)
JournalCurrent Cardiovascular Risk Reports
Issue number4
StatePublished - Apr 2015
Externally publishedYes


  • Cardiovascular disease
  • Ethnicity
  • Health disparities
  • High blood pressure
  • Hypertension
  • Race

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this